Conference Agenda

Investigating Antibodies that Protect from Cerebral Malaria in Kenyan Children

Yuchi Ji¹, Isobel S Walker¹, Niamh Meagher¹, Wina Hasang¹, Sidney Ogolla², David Midem³, J Alexandra Rowe⁴, Stanley Otoboh⁴, Elizabeth H Aitken^1,5, James W Kazura⁶, Stephen J Rogerson¹

1: Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia; 2: Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya; 3: Chulaimbo Sub-County Hospital, Kisumu, Kenya; 4: Institute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, Scotland, UK; 5: Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia; 6: School of Medicine, Centre for Global Health & Diseases, Case Western Reserve University, Cleveland, Ohio, US

Functional antibodies to Plasmodium vivax merozoite antigens are associated with protection against clinical malaria

Chau Quang^1,2, Takaaki Yuguchi³, Eizo Takashima³, Ivo Mueller^1,2, Rhea Longley^1,2,4

1: The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; 2: The University of Melbourne, Melbourne, VIC, Australia; 3: Ehime University, Matsuyama, Japan; 4: Mahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand

Human Plasmodium falciparum sporozoite effector-memory CD8⁺ T cells exhibit epitope-specific activation and display distinct T cell receptor clustering

Roos van Schuijlenburg¹, Max van Houcke², Jeroen Sijtsma¹, Els Baalbergens¹, Helena de Bes-Roeleveld¹, Beatrice Winkel¹, Kirsta E. van Meijgaarden¹, Sander Wuyts², Blandine Franke-Fayard¹, Meta Roestenberg¹

1: Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center, Leiden, Netherlands; 2: Immune Watch, Antwerp, Belgium